c-Met activation promotes extravasation of hepatocellular carcinoma cells into 3D-cultured hepatocyte cells in lab-on-a-chip device

Biochim Biophys Acta Mol Cell Res. 2023 Dec;1870(8):119557. doi: 10.1016/j.bbamcr.2023.119557. Epub 2023 Aug 5.

Abstract

Activation of c-Met signaling is associated with an aggressive phenotype and poor prognosis in hepatocellular carcinoma (HCC); however, its contribution to organ preference in metastasis remains unclear. In this study, using a Lab on a Chip device, we defined the role of aberrant c-Met activation in regulating the extravasation and homing capacity of HCC cells. Our studies showed that (i) c-Met overexpression and activation direct HCC cells preferentially towards the hepatocytes-enriched microenvironment, and (ii) blockage of c-Met phosphorylation by a small molecule inhibitor attenuated extravasation and homing capacity of HCC cells. These results, thus, demonstrate the role of c-Met signaling in regulating the colonization of HCC cells preferentially in the liver.

Keywords: Extravasation; HCC; Lab-on-a-chip (LOC); Metastasis; Microenvironment; c-Met.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular* / pathology
  • Cell Line
  • Hepatocytes
  • Humans
  • Liver Neoplasms* / genetics
  • Liver Neoplasms* / pathology
  • Tumor Microenvironment